1. Home
  2. NE vs ABVX Comparison

NE vs ABVX Comparison

Compare NE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noble Corporation plc A

NE

Noble Corporation plc A

N/A

Current Price

$41.93

Market Cap

8.0B

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$98.23

Market Cap

7.2B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NE
ABVX
Founded
1985
2013
Country
United States
France
Employees
4500
69
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NE
ABVX
Price
$41.93
$98.23
Analyst Decision
Buy
Buy
Analyst Count
7
13
Target Price
$46.00
$131.31
AVG Volume (30 Days)
1.2M
2.5M
Earning Date
04-26-2026
03-23-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$52.14
Revenue Next Year
$9.18
$4,132.27
P/E Ratio
$32.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.24
$7.41
52 Week High
$54.98
$148.83

Technical Indicators

Market Signals
Indicator
NE
ABVX
Relative Strength Index (RSI) 28.25 42.21
Support Level $27.78 $87.60
Resistance Level $47.36 $98.59
Average True Range (ATR) 1.50 6.59
MACD -0.49 0.04
Stochastic Oscillator 1.57 23.57

Price Performance

Historical Comparison
NE
ABVX

About NE Noble Corporation plc A

Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and on deploying its drilling rigs in oil and gas basins around the world. The mobile offshore drilling units comprising the offshore rig fleet operate in international markets for contract drilling services and are often redeployed to different regions due to changing customer demand, which consists mainly of large, integrated, independent, and government-owned or controlled oil and gas companies throughout the world.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: